CLINICAL TRIALS PROFILE FOR CHILDREN'S ZYRTEC ALLERGY
✉ Email this page to a colleague
All Clinical Trials for CHILDREN'S ZYRTEC ALLERGY
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00780403 ↗ | Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed) | Completed | Merck Sharp & Dohme Corp. | Phase 4 | 2005-08-01 | The primary objective of this study was to determine whether children ages 6-11 years prefer desloratadine RediTabs (2.5 mg) or a marketed competitor (Zyrtec® 5 mg Chewable Tablets). The secondary objectives of this study were to compare acceptance of the two attributes, taste and feeling in the mouth, of desloratadine 2.5 mg RediTabs and Zyrtec® 5 mg Chewable Tablets |
| NCT00794378 ↗ | Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03829)(COMPLETED) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2004-11-01 | This study was conducted to compare the taste acceptability of Zyrtec syrup with desloratadine syrup in children. Children between 6 and 11 years of age received 5 mL of each syrup, separated by 15 to 20 minutes on a single day. |
| NCT00794794 ↗ | Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03826) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2004-11-01 | This study was conducted to compare the taste acceptability of Zyrtec syrup with desloratadine syrup in children. Children between 6 and 11 years of age received 5 mL of each syrup, separated by 15 to 20 minutes on a single day. |
| NCT02932774 ↗ | Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR) | Completed | Pfizer | Phase 4 | 2001-03-01 | The objective of this clinical trial was to assess the efficacy and safety of cetirizine HCl syrup vs. loratadine syrup vs. placebo syrup in the treatment of SAR in children 6 to 11 years old. |
| NCT02932774 ↗ | Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR) | Completed | Johnson & Johnson Consumer and Personal Products Worldwide | Phase 4 | 2001-03-01 | The objective of this clinical trial was to assess the efficacy and safety of cetirizine HCl syrup vs. loratadine syrup vs. placebo syrup in the treatment of SAR in children 6 to 11 years old. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CHILDREN'S ZYRTEC ALLERGY
Condition Name
Clinical Trial Progress for CHILDREN'S ZYRTEC ALLERGY
Clinical Trial Phase
Clinical Trial Sponsors for CHILDREN'S ZYRTEC ALLERGY
Sponsor Name
